XPH
State Street SPDR S&P Pharmaceuticals ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$53.25
-0.39 ▼ -0.73%
🌙 3월 13일 7:34 PM ET (한국 3/14 08:34)
$53.15
-0.10 ▼ -0.19%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -2.99% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -7.23% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -5.85% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 5.6 | Perf Half Y | 11.85% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.62M | Perf YTD | -4.93% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -9.5% ($58.84) | Perf Year | 25.03% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 51.18% ($35.22) | Perf 3Y | 32% |
| Dividend Est. | $0.46 (0.87%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 2.3% 2% | Perf 5Y | -2.2% |
| Dividend TTM | 0.46 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.31 | Perf 10Y | 25.56% |
| Dividend Ex-Date | 2025/12/22 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 33.49 | Recom | - |
| Dividend Gr. 3/5Y | -11.55% 13.67% | Current Ratio | - | Sales Q/Q | - | SMA20 | -5.64% ($56.43) | Beta | 0.6 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -5.55% ($56.38) | Rel Volume | 0.25 | Prev Close | $53.64 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 7.7% ($49.44) | Avg Volume(3M) | 0.11M | Price | $53.25 |
| IPO | 2006/6/22 | Option/Short | Yes/Yes | Trades | 266 | Volume | 27,587 | Change | -0.73% |
뉴스 로딩 중...